Education & Training Degree-Granting Education Postgraduate Training Licenses & Certifications Experience & Service Faculty Academic Appointments Associate Professor, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023 Assistant Professor, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017 Administrative Appointments/Responsibilities Co-Chair, Emil J Freireich Leukemia Hematology Grand Rounds, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present Executive Director, Cancer Network, Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present Director, Cancer Network, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present Director, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Program, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present Hematology Consultant, Cancer Network, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2022 Course Director, Leukemia Rotation, Hematology/Oncology Fellowship Program, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present Co-Chair, Leukemia Hematology Grand Rounds, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2021 Other Professional Positions Member, Patient Power Advisory Panel, USA, 2021 - 2021 Chief Fellow Housestaff Education, Hematology/Oncology, The University of Texas MD Anderson Cancer Center Fellowship Program, Houston, TX, 2009 - 2010 Extramural Institutional Committee Activities Consultant, Medical Affairs Hematology Steering Committee 2026, Stemline Therapeutics, Inc, 2026 - Present Member, Cancer Communications Committee for the American Society of Clinical Oncology, ASCO, 2026 - 2029 Co-Chair, Scientific Review Committee (SRC) #3, The University of Texas MD Anderson Cancer Center, 2021 - Present Vice Chair, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present Member, Clinical Research Committee (CRC), The University of Texas MD Anderson Cancer Center, 2015 - 2021 Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2021 Member, Clinical Competence Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present Member, Transfusion Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2016 Member, Fellowship Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present Member, OncoLog Editorial Board, The University of Texas MD Anderson Cancer Center, 2012 - 2017 Member, Interviewing Committee, MD Anderson Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2010 - Present Editorial Activities Contributing Editor, The Hematologist, 2026 - 2028 Associate Editor, Blood Cancers Today, 2022 - 2023 Editorial Board Member, Journal of Immunotherapy and Precision Oncology (JIPO), 2020 - Present Editorial Board Chair, HemOnc Times, 2018 - 2019 Section Editor, Elsevier, 2016 - Present Advisory Board, Oncology Times, 2016 - 2019 Staff Writer, ASH Daily News, 2016 Honors & Awards Professional Memberships Clinical Lymphoma, Myeloma & Leukemia Editorial Board 2020 - Present Journal of Immunotherapy and Precision Oncology (JIPO) Editorial Board 2020 - 2022 The American Society of Hematology (ASH) Committee on Communications 2020 - 2023 American Soceity of Clinical Oncology (ASCO) Cancer.Net Editorial Board 2020 - 2021 SWOG 2015 - Present Harris County Medical Society 2013 - Present Texas Medical Association 2013 - Present American Association for the Advancement of Science 2012 - Present International CML Foundation 2012 - Present School of Science and Engineering Tulane Health Leaders Alumni Group (THLAG) 2012 - Present Johns Hopkins Medical and Surgical Association 2012 - Present American College of Physicians 2011 - Present American Society for Bone and Mineral Research 2011 - 2015 American Association for Cancer Research 2010 - Present American Society of Clinical Oncology (ASCO) 2009 - Present American Society of Hematology (ASH) 2008 - Present Selected Presentations & Talks Local Presentations 2023
Research shows both can increase muscle growth and reduce fat in experimental models, with MK 677 increasing IGF-1 levels significantly and Ipamorelin targeting ghrelin receptors to minimize hormonal fluctuations in research subjects
it was found that amygdalin may support the preservation of gastric mucosal integrity through the generation of mucosal nitric oxide in an experimental gastric ulcer model that would be correlated with ocular diseases [92]
Can Sermorelin be used for sleep research
